Tumor Drug Concentration and Phosphoproteomic Profiles After Two Weeks of Treatment With Sunitinib in Patients with Newly Diagnosed GlioblastomaGBM: Tumor Sunitinib Concentrations and Phosphoproteomics
Article in Clinical Cancer Research (February 2022)